Hasan, A., Lee, J., Payyaula, N., Radhakrishanan, V. V., Sudevan, S. T., Kumar, S., Parambi, D. G. T., Abass, K. S., Kumar, A., Maliyakkal, N., Kim, H., Mathew, B. (2026). Development of 1-(substituted benzofuran-2-yl)-3-(halogen-substituted phenyl)prop-2-en-1-ones as potent, reversible, and selective MAO-B inhibitors for Parkinson’s Disease. Scientific Reports. https://doi.org/10.1038/s41598-026-53367-w